期刊文献+

端粒酶逆转录酶和c-myc基因在肺癌中表达的研究 被引量:1

Expression of telomerase reverse transcriptase and c-myc oncogene in lung cancer
原文传递
导出
摘要 目的 研究端粒酶逆转录酶 (hTERT)和c myc基因在肺癌中的表达及其与端粒酶活性的关系。方法 采用端粒重复序列扩增 (TRAP)法对肺癌组织以及癌旁非癌肺组织的端粒酶活性进行测定。用原位逆转录聚合酶链反应 (RT PCR)和免疫组织化学技术分别检测上述组织标本中hTERTmRNA与c myc蛋白表达。结果 端粒酶活性在肺癌组织中阳性率为 73 .2 % (3 0 /4 1) ,在癌旁非癌肺组织为 6.3 % (2 /3 2 ) ,P <0 .0 1。肺癌及癌旁非癌肺组织中hTERTmRNA阳性表达率分别为 78.0 % (3 2 /4 1)和 9.4% (3 /3 2 ) ,P <0 .0 1,c myc蛋白阳性表达率分别为 80 .5 % (3 3 /4 1)和 15 .6% (5 /3 2 ) ,P <0 .0 1。肺癌组织hTERTmRNA表达与端粒酶活性呈显著正相关 (r =0 .70 7,P <0 .0 1) ,同时c myc蛋白与hTERTmRNA表达亦呈明显正相关 (r =0 .60 9,P <0 .0 1)。 结论 hTERTmRNA表达增强不仅参与肺癌的发生 ,而且可能是调节肺癌端粒酶活性的限速步骤。c Objective To investigate the expression of human telomerase reverse transcriptase(hTERT)and c-myc oncogene and its relation to telomerase activity in the carcinogenesis of lung cancer.Methods Telomerase activity was detected in tissues samples from lung cancers and adjacent non-cancer lung tissues by telomeric repeat amplification protocol(TRAP).The hTERTmRNA and c-myc oncoprotein were examined in these samples with in situ reverse transcription polymerase chain reaction and immunohistochemical method,respectively.Results The positive rates of telomerase activity and hTERT mRNA were 73.2% and 78.0% in 41 samples of lung cancers,respectively,significantly higher than those of adjacent non-cancer lung tissues group( P <0.01).It was found that c-myc oncoprotein was positive in 80.5% (33/41) samples of lung cancers and in 15.6%(5/41)adjacent non-cancer lung tissues( P < 0.01). There was a significant correlation between the expression of hTERTmRNA and telomerase activity( r =0.707, P <0.01).The expressions of c-myc oncoprotein and hTERTmRNA were also noticed to be highly correlated( r =0.609, P <0.01).Conclusion The overexpression of hTERTmRNA may play an important role in the carcinogenesis of lung cancer and telomerase activation.The c-myc oncoprotein may trans-activate hTERTmRNA overexpression,which is related to the development of lung cancer.
作者 陈杰
出处 《临床内科杂志》 CAS 北大核心 2003年第11期580-582,共3页 Journal of Clinical Internal Medicine
关键词 肺肿瘤 端粒酶 端粒酶逆转录酶 c—myc基因 Lung neoplasms Telomerase Human telomerase reverse transcriptase c-myc
  • 相关文献

参考文献10

  • 1曲波,李宝杰,吕志武,潘海乐.细针肝穿刺标本检测端粒酶诊断肝癌的意义[J].世界华人消化杂志,2001,9(5):538-540. 被引量:14
  • 2方向明,于皆平,余保平,沈志祥,罗和生.大肠癌组织端粒酶各组分基因表达及其与端粒酶活性的关系[J].临床内科杂志,2002,19(2):112-113. 被引量:3
  • 3Hiyama K, Hiyama E, Ishioka S,et al. Telomerase activity in small-cell and non- small-cell lung cancers. J Natl Cancer Inst, 1995,87 : 895-902.
  • 4Jong HS, Park YI, Kim S, et al. Up-regulation of human telomerase catalyric subunit during gastric carcinogenesis. Cancer, 1999,8:559-565.
  • 5Cong YS, Wen J, B-acchetti S. The human telomerase catalytic subunit:organization of the gene and characterization of the promoter. Hum Mo lGenet, 1999,8 : 137-142.
  • 6Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science, 1997,277 : 955-959.
  • 7Kyo S, Kanaya T, Takakura M, et al. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int J Cancer, 1999,80:60-63.
  • 8vMeyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 1997,90:785-795.
  • 9Kevin MR, George BD. Myc oncogenes: the enigmatic family. Biochem J, 1996,314:7133-7136.
  • 10Greenberg RA,O' Hagan RC, Deng H, et al. Telomerase reverse transcriptase gene is a direct target of c-myc but not functionally equivalent in cellular transformation. Oncogene, 1999,18 : 1219-1226.

二级参考文献12

共引文献15

同被引文献19

  • 1Pei L, Melmed S. Isolation and characterization of a Pituitary tumor-transforming geng (PTTG) [J]. Mol Endocrinol, 1997, 11: 433.
  • 2Dominguez A, Ramos-Morales F, Romero F, et al. hPTTG, a human homologue of rat PTTG, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG [J]. Oncogene,1998,17 :2187.
  • 3Zhang X, Horwitz GA, Prezant TR, et al. Structure, expression, and function of human pituitary tumor-transforming geng (PTTG)[J]. Mol Endocrinol, 1999, 13: 156.
  • 4Prezant TR, Kadioglu P, Melmed S. An intronless homolog human proto-oncogene hPTTG is expressed in pituitary tumors: evidence for hPTTG family[J]. J Clin Endocrinol Metab, 1999, 84: 1149.
  • 5Chen L, Puri R, Kakar SS, et al. Identification of the human pituitary tumor transforming geng (hPTTG) family: molecular structure, expression, and chromosomal localization [J]. Gene, 2000, 248: 41.
  • 6Strausberg RL, Dahl CA, Klausner RD .New opportunities for uncovering the molecular basis of cancer [J]. Nat Genet, 1997, 15: 415.
  • 7Pei L. Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene trsnsactivation function [J]. J Biol Chem, 2000, 275: 31191.
  • 8YU R, Heaney A, Lu W, et al. Pituitary tumor transforming gene (PTTG) causes aneuploidy and p53-dependent and p53-inpendent apoptosis[J]. J Biol Chem, 2000, 275: 36502.
  • 9Heaney AP, Horwitz GA, Wang Z, et al. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis [J]. Nat Med, 1999, 5: 1317.
  • 10Shibata Y, Haruke N, Kuwabara Y, et al. Expression of pituitary-tumor transforming gene in esophageal cancer [J]. Jap J Clin Oncol, 2002, 32(7): 233.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部